BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Biotech Bay

  BioMarin to Participate in Bank of America 2023 Health Care Conference

  BioMarin Pharmaceutical Inc. announced that Brian Mueller, Executive Vice President, Chief Financial Officer of BioMarin will present at the Bank of America 2023 Health Care Conference on Wednesday, May 10, 2023 at 3:40pm PT, in Las Vegas, NV.

  May 4, 2023

   · 

  1 min read
• BioCapital

  Novavax to Participate in the BofA Securities 2023 Health Care Conference

  Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, announced that it will participate in the BofA Securities 2023 Health Care Conference.

  May 4, 2023

   · 

  1 min read
• Business

  Schrödinger Reports Strong First Quarter 2023 Financial Results

  Schrödinger, Inc., whose physics-based computational platform is transforming the way therapeutics and materials are discovered, announced financial results for the first quarter ended March 31, 2023.

  May 4, 2023

   · 

  19 min read
• Business

  Ligand Reports First Quarter 2023 Financial Results

  Ligand Pharmaceuticals Incorporated reported financial results for the three months ended March 31, 2023, and provided an operating forecast and business updates.

  May 4, 2023

   · 

  23 min read
• Biotech Bay

  4D Molecular Therapeutics Announces Proposed Public Offering of Common Stock - May 04, 2023

  4D Molecular Therapeutics, Inc., a clinical-stage biotherapeutics company harnessing the power of directed evolution for genetic medicines targeting large market diseases, announced that it has commenced an underwritten public offering of $100.0 million of shares of its common stock.

  May 4, 2023

   · 

  5 min read
• Biotech Bay

  SI-BONE Announces Launch of Public Offering of Common Stock - May 04, 2023

  SI-BONE, Inc., a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced that it has commenced an underwritten public offering of 3,775,000 shares of its common stock.

  May 4, 2023

   · 

  3 min read
• Business

  Cardiff Oncology Reports First-Quarter 2023 Results and Provides Business Update

  Cardiff Oncology, Inc. announced financial results for the first-quarter ended March 31, 2023, and provided a business update.

  May 4, 2023

   · 

  9 min read
• Business

  SenesTech to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023

  SenesTech, Inc. will report financial results for its first quarter 2023, ended March 31, 2023, after the market close on Thursday, May 11, 2023.

  May 4, 2023

   · 

  3 min read
• Business

  Nuvation Bio Reports First Quarter 2023 Financial Results and Provides Business Update

  Nuvation Bio Inc., a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, reported its financial results for the first quarter ended March 31, 2023, and provided a business update.

  May 4, 2023

   · 

  7 min read
• Biotech Bay

  Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting

  Spruce Biosciences, Inc. announced that a submitted abstract was accepted for poster presentation at the Pediatric Endocrine Society 2023 Annual Meeting taking place May 5-8, 2023, in San Diego, Calif.

  May 4, 2023

   · 

  1 min read